129 related articles for article (PubMed ID: 371800)
21. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
22. Long-term cryopreservation of autologous bone marrow: analysis of granulocyte-macrophage progenitor (CFU-GM) viability in 31 samples stored more than 48 months.
Lemoli RM; Visani G; Motta MR; Rizzi S; Ricci P; Bandini G; Poluzzi C; Tura S
Haematologica; 1988; 73(2):101-4. PubMed ID: 3044937
[No Abstract] [Full Text] [Related]
23. Successful infusion of 40 cryopreserved autologous bone-marrows. In vitro studies of the freezing procedure.
Beaujean F; Hartmann O; Le Forestier C; Bayet S; Duédari N; Parmentier C
Biomed Pharmacother; 1984; 38(7):348-52. PubMed ID: 6395915
[TBL] [Abstract][Full Text] [Related]
24. [Use of human albumin as an additional cryoprotective agent in freeze preservation of hematopoietic stem cells].
Reiners B; Zintl F; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(2):264-72. PubMed ID: 2440783
[TBL] [Abstract][Full Text] [Related]
25. Crypreservation and reinfusion of autologous bone marrow enriched for clonogenic stem cells by discontinuous cell centrifugation.
De Witte T; Van den Ouweland F; Raymakers R; Geerdink P; Wessels J; Haanen C
Neth J Med; 1983; 26(3):67-73. PubMed ID: 6133226
[No Abstract] [Full Text] [Related]
26. Cryopreserved autologous bone marrow transplantation in the treatment of selected pediatric malignancies: a preliminary report.
Kaizer H; Leventhal BG; Wharam MD; Munoz LL; Elfenbein GJ; Tutschka PJ; Santos GW
Transplant Proc; 1979 Mar; 11(1):208-11. PubMed ID: 377634
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of colony growth and hematologic engraftment in patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for breast cancer.
Meehan KR; Ericson SG; Tosteson TD; Mills LE
Prog Clin Biol Res; 1994; 389():497-503. PubMed ID: 7535459
[No Abstract] [Full Text] [Related]
28. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
29. Quantitative problems in bone marrow transplantation by peripheral blood stem cells.
Serafimov-Dimitrov V
Haematologia (Budap); 1986; 19(2):141-6. PubMed ID: 3530907
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing reconstitution by bone marrow transplantation.
van Bekkum DW; Wielenga JJ; van Gils F; Wagemaker G
Prog Clin Biol Res; 1990; 352():479-91. PubMed ID: 1698302
[TBL] [Abstract][Full Text] [Related]
31. [Freeze preservation of hematopoietic stem cells].
Herve P
Rev Fr Transfus Immunohematol; 1981 Dec; 24(6):609-30. PubMed ID: 6120560
[No Abstract] [Full Text] [Related]
32. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
33. Autologous stem cell reconstitution and the intensive therapy of resistant solid tumors in man.
Deisseroth A; Abrams R
Exp Hematol; 1979; 7 Suppl 5():347-50. PubMed ID: 45458
[No Abstract] [Full Text] [Related]
34. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
To LB; Roberts MM; Haylock DN; Dyson PG; Branford AL; Thorp D; Ho JQ; Dart GW; Horvath N; Davy ML
Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938
[TBL] [Abstract][Full Text] [Related]
35. Yield of primed progenitor cells as determined by days of priming with recombinant human granulocyte-colony stimulating factor.
Ericson SG; Meehan KR; Tosteson TD; Mills LE
Prog Clin Biol Res; 1994; 389():449-55. PubMed ID: 7535453
[No Abstract] [Full Text] [Related]
36. Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
Siena S; Bregni M; Bonsi L; Strippoli P; Peccatori F; Magni M; Di Nicola M; Bagnara GP; Massimo Gianni A
Stem Cells; 1993 Jul; 11 Suppl 2():72-5. PubMed ID: 8104618
[TBL] [Abstract][Full Text] [Related]
37. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Lobo F; Kessinger A; Landmark JD; Smith DM; Weisenburger DD; Wigton RS; Armitage JO
Bone Marrow Transplant; 1991 Nov; 8(5):389-92. PubMed ID: 1685105
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of peripheral blood stem cells: comparing cyclophosphamide and growth factor based regimens.
Janssen WE; Smilee R; Carter R; Rahn D; Cairo M; Hiemenz JH; Zorsky PE; Fields KK; Ballester O; Perkins J
Prog Clin Biol Res; 1994; 389():429-39. PubMed ID: 7700915
[No Abstract] [Full Text] [Related]
39. [Morphological characteristics of the hematopoietic colony cells after the transplantation of cryopreserved bone marrow].
Kogut GI; Nastenko EP; Shatrova KM; Glukhen'kaia GT
Vrach Delo; 1987 Mar; (3):72-4. PubMed ID: 3296450
[No Abstract] [Full Text] [Related]
40. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
Douay L; Gorin NC; Lopez M; Casellas P; Liance MC; Jansen FK; Voisin GA; Baillou C; Laporte JP; Najman A
Cancer Res; 1985 Jan; 45(1):438-41. PubMed ID: 3880666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
